Browse Antiarthritic agents topic

Product development subtopic

Articles 1-21 out of 21 article(s) Title Author Type Date Words Idera Pharmaceuticals Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel[R] in Arthritis Model. Oct 19, 2009 886 Plexxikon Treats Initial Patient with First-in-Class Drug in Phase 1 Trial. Oct 8, 2009 789 Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthritis Drug. Sep 22, 2009 838 Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gastrointestinal Injuries. Clinical report Jul 1, 2009 1291 Emisphere Technologies Announces the Completion of Enrollment in Second Phase III Study for Oral Osteoarthritis Treatment Utilizing Proprietary Eligen[R] Technology. Report Jun 1, 2009 592 Can-Fite BioPharma to Initiate Phase I/II Clinical Trial With CF102 for the Treatment of Liver Cancer. Apr 16, 2009 574 CombinatoRx Completes Enrollment in Phase 2B Clinical Trial of CRx-102 in Knee Osteoarthritis. Clinical report May 27, 2008 955 Research and Markets: Report 'Current Clinical Trials: Rheumatology' Analyses New Drugs in Phase II and III Clinical Trials Based On Data from the Leading Clinical Trials Database, Trialtrove. Jan 9, 2008 239 Can-Fite to Conduct a Confirmatory Phase IIb Trial in Early 2008 as Part of Ongoing Development of CF101 for the Treatment of Rheumatoid Arthritis. Oct 23, 2007 607 CombinatoRx Announces Initiation of Phase 2b Clinical Study of CRx-102 in Knee Osteoarthritis. Clinical report Sep 26, 2007 934 Hollis-Eden plans clinical trial for arthritis treatment. Chambers, Heather Sep 24, 2007 186 Sucampo Pharmaceuticals Initiates Phase 2, Dose-Finding Trial of Cobiprostone for the Prevention of NSAID-Induced Ulcers in Arthritis Patients. Sep 20, 2007 953 Fungus infection killed patient; Targeted Genetics' clinical trial; Role of injection is still uncertain. Aug 18, 2007 639 Patient in arthritis-drug trial dies; Targeted Genetics; Company, FDA investigating if drug related to death. Jul 27, 2007 405 Clinical trial halted after patient became ill; Biotechnology; Unclear if illness was caused by arthritis drug. Jul 25, 2007 321 Idera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Rheumatoid Arthritis Models. Jul 17, 2007 716 Can-Fite to Commence Phase II Clinical Trials to Investigate the Efficacy of CF101 in the Treatment of Psoriasis. May 16, 2007 644 FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib). Apr 12, 2007 615 KaloBios Commences Clinical Trial of Novel Antibody Rheumatoid Arthritis Drug Candidate. Nov 9, 2006 405 Kemia Announces Completion of Phase I Trials for Oral Anti-Inflammatory Drug; KC706, a p38 MAP Kinase Inhibitor, Targets Inflammatory Conditions Including Arthritis, Psoriasis, and Cardiovascular Disease. Aug 23, 2006 678 Targeted Genetics Initiates Next Clinical Trial of tgAAC94 in Inflammatory Arthritis. Oct 11, 2005 1365